Fred Alger Management, LLC Abcam PLC Transaction History

Fred Alger Management, LLC

  • $19.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$21.54 - $24.41 $76.6 Million - $86.8 Million
-3,556,465 Reduced 95.13%
182,111 $4.12 Million
Q2 2023

Aug 14, 2023
BUY
$12.62 - $24.47 $47.2 Million - $91.5 Million
3,738,576 New
3,738,576 $91.5 Million
Q2 2021

Aug 16, 2021
SELL
$18.47 - $22.11 $312,937 - $374,609
-16,943 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$19.22 - $24.3 $325,644 - $411,714
16,943 New
16,943 $326,000

Others Institutions Holding ABCM

# of Institutions
4
Shares Held
1.03M
Call Options Held
0
Put Options Held
0
View Full List

About Abcam plc

ABCM Quotes by TradingView
  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email